Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Office of the Director
Grant: P51OD011107
National Institute of Allergy and Infectious Diseases
Grant: 1R21AI143454-02S1
National Institute of Allergy and Infectious Diseases
Grant: 3RF1AG061001
NIAID NIH HHS
Grant: R21 AI143454
NIA NIH HHS
Grant: RF1 AG061001
National Institutes of Health
Grant: 3R21AI143454-02S1
Convalescent plasma therapy for COVID-19
National Institutes of Health
Grant: 8P51OD011107-51
California National Primate Research Center
National Institutes of Health
Grant: 3RF1AG061001-01S3
Investigating the Role of T cells in Age-related Neurodegeneration in HIV Infection
FWCI
1.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals